Cytokinetics Inc (CYTK): EBITDA
-$602.13M
Year ended 2025-12-31
-$695.36M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$602.13M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$526.72M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$484.31M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$318.39M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$184.04M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$92.11M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$97.57M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$87.68M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$111.48M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $19.43M | n/m | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | -$36.82M | n/m | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | -$14.26M | n/m | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | -$33.46M | n/m | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | -$39.87M | n/m | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | -$46.67M | n/m | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | -$47.73M | n/m | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $28.12M | n/a | 2012-03-13, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$602.13M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | -$100.99M | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$178.08M | n/m |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | -$276.93M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$73.23M | n/m |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $24.26M | -65.6% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $3.20M | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | -$58.89M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$240.64M | n/m |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗